Plasma cGMP and large artery remodeling in asymptomatic men

Hypertension

Volumn 44, Issue 6, 2004, Pages 919-923

  Devynck, Marie Aude ^a   Simon, Alain ^a,b   Pernollet, Marie Gabrielle ^a   Chironi, Gilles ^a   Gariepy, Jérôme ^a   Rendu, Francine ^a   Levenson, Jaime ^a  

^a Centre de Medecine Preventive   (France)

^b HÔPITAL BROUSSAIS   (France)

Author keywords

Arteries; Atherosclerosis; Cyclic GMP; Endothelium; Nitric oxide; Remodeling

Indexed keywords

C REACTIVE PROTEIN; CYCLIC GMP;

ADULT; ARTERY DIAMETER; ARTERY INTIMA; ARTERY MEDIA; ARTERY WALL; ARTICLE; ATHEROSCLEROTIC PLAQUE; BLOOD LEVEL; CARDIOVASCULAR RISK; CAROTID ARTERY; CONTROLLED STUDY; GEOMETRY; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; SYMPTOMATOLOGY; TISSUE REPAIR;

ARTERIOSCLEROSIS; C-REACTIVE PROTEIN; CAROTID ARTERIES; CYCLIC GMP; HUMANS; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; RISK FACTORS; TUNICA INTIMA;

EID: 9644284301     PISSN: 0194911X     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.HYP.0000145862.33770.e9     Document Type: Article

References (17)

1. Münzel T, Feil R, Mülsch A, Lohmann SM, Hofmann F, Walter U. Physiology and pathophysiology of vascular signaling controlled by cyclic guanosine 3′,5′-cyclic monophosphate-dependent protein kinase. Circulation. 2003;108:2172-2183.
2. Rybalkin SD, Yan C, Bornfeldt KE, Beavo JA. Cyclic GMP phosphodiesterases and regulation of smooth muscle function. Circ Res. 2003;93:280-291.
3. Wolfsgruber W, Feil S, Brummer S, Kuppinger O, Hofmann F, Feil R. A pro-atherogenic role for cGMP-dependent protein kinase in vascular smooth muscle cells. Proc Natl Acad Sci U S A. 2003;100:13519-13524.
4. Lincoln TM, Dey N, Sellak H. cGMP-dependent protein kinase signaling mechanisms in smooth muscle: from the regulation of tone to gene expression. J Appl Physiol. 2001;91:1421-1430.
5. Kuhlencordt PJ, Chen J, Han F, Astern J, Huang PL. Genetic deficiency of inducible nitric oxide synthase reduces atherosclerosis and lowers plasma lipid peroxides in apolipoprotein E-knockout mice. Circulation. 2001;103:3099-3104.
6. Denarie N, Gariepy J, Chironi G, Massonneau M, Laskri F, Salomon J, Levenson J, Simon A. Distribution of ultrasonographically assessed dimensions of common carotid arteries in healthy adults of both sexes. Atherosclerosis. 2000;148:297-302.
7. Chironi G, Gariepy J, Denarie N, Balice M, Megnien JL, Levenson J, Simon A. Influence of hypertension on early carotid artery remodeling. Arterioscler Thromb Vasc Biol. 2003;23:1460-1464.
8. Simon A, Giral O, Levenson J. Extracoronary atherosclerotic plaque at multiple sites and total coronary calcification deposit in asymptomatic men. Association with coronary risk profile. Circulation. 1995;92:1414-1421.
9. Ridker PM, Hennekens CH, Buring JE, Rifai N. C-reactive protein and other markers of inflammation in prediction of cardiovascular disease in women. N Engl J Med. 2000;342:836-843.
10. - in aquous and protein-containing samples. Nitric Oxide. 1999;3:225-234.
11. Graf S, Gariepy J, Massonneau M, Armentano RL, Mansour S, Barra JG, Simon A, Levenson J. Experimental and clinical validation of arterial diameter waveform and intimai media thickness obtained from B-mode ultrasound image processing. Ultrasound Med Biol. 1999;25:1353-1363.
12. Simon A, Gariepy J, Moyse D Levenson J. Differential effects of nifedipine and co-amilozide on the progression of early carotid wall changes. Circulation. 2001;103:2949-2954.
13. Kielstein JT, Impraim B, Simmel S, Bode-Boger SM, Tsikas D, Frôlich JC, Hoeper MM, Haller H, Fliser D. Cardiovascular effects of systemic nitric oxide synthase inhibition with asymmetrical dimethylarginine in humans. Circulation. 2004;109:172-177.
14. Hamet P, Pang SC, Tremblay J. Atrial natriuretic factor-induced egression of cyclic guanosine 3 5-monophosphate in cultured vascular smooth muscle and endothelial cells. J Biol Chem. 1989;264:12364-12369.
15. Mercapide J, Santiago E, Alberdi E, Martinez-Irujo JJ. Contribution of phosphodiesterase isoenzymes and cyclic nucleotide efflux to the regulation of cyclic GMP levels in aortic smooth muscle cells. Biochem Pharmacol. 1999;58:1675-1683.
16. Simon A, Gariepy J, Chironi G, Megnien JL, Levenson J. Intima-media thickness: a new tool for diagnosis and treatment of cardiovascular risk. J Hypertens. 2002;20:159-169.
17. Tao L, Liu HR, Gao E, Teng ZP, Lopez BL, Christopher TA, Ma XL, Batinic-Haberle I, Willette RN, Ohlstein EH, Yue TL. Antioxidative, antinitrative, and vasculoprotective effects of a peroxisome proliferator-activated receptor-gamma agonist in hypercholesterolemia. Circulation. 2003;108:2805-2811.